Cardiovascular Disease
Few adults with type 2 diabetes use SGLT2 inhibitors, GLP-1 receptor agonists
Fewer than one in 10 adults with type 2 diabetes in the U.S. use SGLT2 inhibitors or GLP-1 receptor agonists, and only SGLT2 inhibitors have seen an increase in use over the last decade, according to study findings.
Consider lower BMI cutoffs for diabetes, CVD risk screening in patients of Asian descent
Nationwide, there is significantly increased interest and focus on addressing racial and ethnic health disparities.
Women’s CV risk increases with age, not reproductive stage
Menopausal women tend to have worse cardiovascular risk profiles than premenopausal women, but 5-year increases in CV risk factors are not dependent on reproductive stage, according to data from the CoLaus study.
COVID-19 leading cause of death in people with diabetes in fourth quarter of 2020
The proportion of deaths attributed to COVID-19 in people with diabetes in the U.S. in the last 3 months of 2020 was slightly higher than the percentage of people who died due to cardiovascular disease or diabetes, according to study data.
Sheehan’s syndrome in GH-naive women may increase CV risk
SAN DIEGO — Women with Sheehan’s syndrome and growth hormone deficiency have higher total cholesterol and triglycerides and higher inflammatory markers compared with healthy adults, according to a speaker.
Liver fat percentage does not alter risk for CV events
SAN DIEGO — Liver fat content is not associated with risk for any cardiovascular event, according to data from the Dallas Heart Study presented at the AACE Annual Scientific and Clinical Conference.
Cardiovascular disease more prevalent in lean vs. overweight, obese patients with NAFLD
Lean patients with nonalcoholic fatty liver disease were at greater risk for cardiovascular and chronic kidney disease compared with overweight or obese patients, according to a researcher at the Digestive Disease Week 2022 media briefing.
Nephritis, phospholipid antibodies contribute to cardiovascular risk in lupus
DESTIN, Fla. — Nephritis and phospholipid antibodies should be considered as contributors to cardiovascular disease risk in patients with systemic lupus erythematosus, according to a speaker at the Congress of Clinical Rheumatology East.
Chronic respiratory symptoms in young adulthood increase risk for later-life CVD, mortality
Chronic respiratory symptoms in young adulthood were associated with increased risk for cardiovascular disease and all-cause mortality in midlife, independent of CV risk factors, smoking and lung function, researchers reported in Chest.
Greater coffee consumption correlates with lower risk for AKI, compared with no coffee
Compared with individuals who never drink coffee, those who consume a large amount of coffee are at a lower risk for incident AKI, according to data published in Kidney International Reports.